import emod_api.campaign as camp
import emodpy_malaria.interventions.treatment_seeking as cm
cm.add_treatment_seeking(camp, start_day=0, drug=['Artemether', 'Lumefantrine'],
targets=[{'trigger': 'NewClinicalCase',
'coverage': 0.7, 'agemin': 0, 'agemax': 5,
'seek': 1,'rate': 0.3},
{'trigger': 'NewClinicalCase',
'coverage': 0.5, 'agemin': 5, 'agemax': 100,
'seek': 1,'rate': 0.3},
{'trigger': 'NewSevereCase',
'coverage': 0.85, 'agemin': 0, 'agemax': 100,
'seek': 1,'rate': 0.5}],
broadcast_event_name="Received_Treatment")Treatment-Seeking
Management of symptomatic cases
Case Management/Treatment-Seeking
Case management is controlled in EMOD by an add_treatment_seeking() function within emodpy-malaria. This function is a node level intervention that allows you to target individuals on the node for malaria treatment through treatment seeking behavior.
In this example, treatment is triggered by new cases and codes for differences in case management coverage between individuals of age 0-5 yrs and 5-100yrs as set by the two trigger dictionaries’ respective agemin and agemax. Importantly, we distinguish between NewClinicalCase and NewSevereCase to provide slightly different case management for uncomplicated and severe cases. In the example below, the main differences for these types of case management are seen in coverage level and the rate of receiving treatment after seeking care, rate. This rate is used to create an exponential distribution of the delay period. We usually set rate = 1/3 for clinical cases and rate = 1/2. for severe cases.
The seek argument dictates the proportion of people who will seek care with a new clinical case - it is usually set to 1 such that coverage is the true case management coverage level.
You can also specify which drugs are used for case management. The default is Artemether-Lumefantrine with age-based dosing. Pre-configured drugs can be viewed in the emodpy-malaria repositry here.
Additional parameters can be added to restrict case management to certain nodes, node properties, or individual properties. See here for more information.